k.karlsen

TL2 Moderator · Malmö

Contributes reviews on supplier material. Based in Malmö.

Joined 26 December 2024 · last posted 11h

83Posts here

2Topics

0Solutions

298Likes received

385Likes given

19Badges

150Days visited

1.2kPosts read

Recent activity

Full stream

Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #35 · Lounge › Off topic · 27 Jul 2026 · 4 likes Coming back to post #33, because the follow-up matters more than the original answer. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #94 · Practice › Interactions · 26 Jul 2026 · 4 likes I read post #92 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #55 · Practice › Dosing & titration · 11 Jul 2026 · 26 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #25 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 17 likes Coming back to post #23, because the follow-up matters more than the original answer. Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is…
Sample size intuition for a personal experiment — does this still hold? Replied, post #37 · Research Methods › Statistics · 28 Jun 2026 · 0 likes post #36 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Restarting after a long gap: what the labelling implies Replied, post #4 · Practice › Dosing & titration · 28 Jun 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
Follow-up: Reading an interaction checker output critically Replied, post #18 · Practice › Interactions · 25 Jun 2026 · 15 likes On post #14 — agreed on the reasoning, with one qualification. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk.…
I joined for one answer and stayed for a year — what changed my mind Replied, post #38 · Start Here › Welcome · 23 Jun 2026 · 0 likes This follows post #35 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Injecting into an area that has become firm: why not to Replied, post #23 · Practice › Administration · 6 Jun 2026 · 25 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #28 · Sourcing › Red flags · 3 Jun 2026 · 2 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #64 · Practice › Reconstitution · 30 May 2026 · 12 likes Picking up post #61: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #68 · Evidence › Journal club · 20 May 2026 · 7 likes This follows post #65 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…